Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1α (CCL3) after allogeneic BMT in mice

Blood

Volumn 101, Issue 9, 2003, Pages 3714-3721

  Panoskaltsis Mortari, Angela ^a   Hermanson, John R ^b   Taras, Elizabeth ^b   Wangensteen, O Douglas ^b   Serody, Jonathan S ^b   Blazar, Bruce R ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOLYSIN; GRANZYME A; GRANZYME B; INTERLEUKIN 13; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; CHEMOKINE; CYTOKINE; GRANZYME; GZMB PROTEIN, MOUSE; MACROPHAGE INFLAMMATORY PROTEIN 1; SERINE PROTEINASE;

ACCELERATION; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; IDIOPATHIC DISEASE; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; SPLEEN CELL; T LYMPHOCYTE; WILD TYPE; ALLOTRANSPLANTATION; ANIMAL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHEMISTRY; GENETICS; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; LUNG; LUNG COMPLIANCE; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION CHIMERA; TH1 CELL; TIME; TRANSPLANTATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; GRAFT VS HOST DISEASE; GRANZYMES; LUNG; LUNG COMPLIANCE; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA; RADIATION CHIMERA; SERINE ENDOPEPTIDASES; TH1 CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0038204156     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-08-2465     Document Type: Article

References (38)

1. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis. 1993;147:1601-1606.
2. Down JD, Mauch P, Warhol M, Neben S, Ferrara JLM. The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation. Transplantation. 1992;54:802-808.
3. Panoskaltsis-Mortari A, Taylor PA, Yaeger TM, et al. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J Clin Invest. 1997;100:1015-1027.
4. Panoskaltsis-Morlari A, Ingbar DH, Jung P, et al. Keratinocyte growth factor (KGF) given before conditioning decreases B7 ligand and granzyme B expression in situ and hastens lung repair post-allogeneic bone marrow transplantation (BMT) in mice. Am J Physiol Lung Cell Mol Physiol. 2000;278:L988-L999.
5. Haddad IY, Panoskaltsis-Mortari A, Ingbar DH, Yang S, Milla CE, Blazar BR. High levels of peroxynitrite are generated in the lungs of irradiated mice given cyclophosphamide and allogeneic T cells: a potential mechanism of injury after marrow transplantation. Am J Respir Cell Mol Biol. 1999;20:1125-1135.
6. Panoskaltsis-Mortari A, Strieter RM, Hermanson JR, et al. Induction of monocyte- and T cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome (IPS) following allogeneic murine bone marrow transplantation (BMT). Blood. 2000;96:834-839.
7. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin D. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science. 1993;260:355-358.
8. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med. 1993;177:1821-1826.
9. Serody JS, Cook DN, Kirby SL, Reap E, Shea TC, Frelinger JA. Murine T lymphocytes incapable of producing macrophage inhibitory protein-1α are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrier. Blood. 1999;93:43-50.
10. Serody JS, Burkett SE, Panoskaltsis-Mortari A, et al. T-lymphocyte production of macrophage inhibitory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung and spleen during graft-versus-host disease. Blood. 2000;96:2973-2980.
11. Blazar BR, Taylor PA, Linsley PS, Vallera DA. In vivo blockade of CD28/CTLA4:B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex (MHC) barrier in mice. Blood. 1994;83:3815-3825.
12. Blazar BR, Sharpe AH, Taylor PA, et al. The infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ cells. J Immunol. 1996;157:3250-3259.
13. Graham GJ, Wright EG, Hewick R, et al. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature. 1990;344:442-444.
14. Cook DN. The role of MIP-1 alpha in inflammation and hematopoiesis. J Leukoc Biol. 1996;59:61-68.
15. Wangensteen D, Piper R, Johnson JA, Sinha AA, Niewoehner D. Solute conductance of blood-gas barrier in hamsters exposed to hyperoxia. J Appl Physiol. 1986;60:1908-1916.
16. Blazar BR, Taylor PA, McElmurry R. Engraftment of severe combined immune deficient (SCID) mice given allogeneic bone marrow (BM) via in utero or post-natal transfer. Blood. 1998;92:3949-3959.
17. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA. Coblockade of the LFA: ICAM and CD 28/CTLA-4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood. 1995;85:2607-2618.
18. Panoskaltsis-Mortari A, Bucy RP. In situ hybridization with digoxigenin-labeled RNA probes: facts and artifacts. Biotechniques. 1995;18:300-308.
19. Smith RE, Strieter RM, Phan SH, et al. Production and function of murine macrophage inflammatory protein-1 alpha in bleomycin-induced lung injury. J Immunol. 1994;153:4704-4712.
20. Mural M, Yoneyama H, Harada A, et al. Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest. 1999;104:49-57.
21. Olszewski MA, Huffnagle GB, McDonald RA, et al. The role of macrophage inflammatory protein-1a/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol. 2000;165:6429-6436.
22. Domachowske JB, Bonville CA, Gao J-L, Murphy PM, Easton AJ, Rosenberg HF. The chemokine macrophage-inflammatory protein-1a and Its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol. 2000;165:2677-2682.
23. Tran EH, Kuziel WA, Owens T. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1 alpha or its CCR5 receptor. Eur J Immunol. 2000;30:1410-1415.
24. Zou LP, Pelidou SH, Abbas N, et al. Dynamics of production of MIP-1 alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol. 1999;98:168-175.
25. McMahon EJ, Cook DN, Suzuki K, Matsushima GK. Absence of macrophage-inflammatory protein-1 alpha delays central nervous system demyelination in the presence of intact blood-brain barrier. J Immunol. 2001;167:2964-2971.
26. Cameron MJ, Arreaza GA, Grattan M, et al. Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. J Immunol. 2000;165:1102-1110.
27. Murphy WJ, Tian Z-G, Asai O, et al. Chemokines and T lymphocyte activation, II: facilitation of human T cell trafficking in severe combined immunodeficiency mice. J Immunol. 1996;156:2104-2111.
28. Bless NM, Huber-Lang M, Guo RF, et al. Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J Immunol. 2000;164:2650-2659.
29. Kamin-Lewis R, Abdelwahab SF, Trang C, et al. Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta-chemokine macrophage inflammatory protein-1 beta. Proc Natl Acad Sci U S A. 2001;98:9283-9288.
30. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new lymphokine regulating inflammatory and immune responses. Nature. 1993;362:248-250.
31. Fowler DH, Kurasawa K, Husebekk A, Cohen PA, Gress RE. Cells of TH2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction: regulation of cytokines and CD8+ lymphoid engraftment. J Immunol. 1994;152:1004-1010.
32. Ottersbach K, Cook DN, Kuziel WA, et al. Macrophage inflammatory protein-1α uses a novel receptor for primitive hemopoietic cell inhibition. Blood. 2001;98:3476-3478.
33. Zhou Z, Kim YJ, Pollok K, et al. Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes. J Immunol. 1993;151:4333-4341.
34. Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Chemokines and T lymphocyte activation, I: beta chemokines costimulate human T lymphocyte activation in vitro. J Immunol. 1996;156:2095-2103.
35. Lukacs NW, Chensue SW, Karpus WJ, et al. C-C chemokines differentially alter interleukin-4 production from lymphocytes. Am J Pathol. 1997;150:1861-1868.
36. McHugh RS, Whitters MJ, Piccirillo CA, et al. CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002;16:311-323.
37. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99:3493-3499.
38. Lu B, Rutledge BJ, Gu L, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 1998;187:601-608.